New heart health biopharmaceutical company Kardigan, which counts among its co-founders the director for Northwestern ...
BMY is looking to turn its business around, banking on the strong uptake of new drugs. The recent spate of positive ...
Hosted on MSN5h
What Analyst Projections for Key Metrics Reveal About Bristol Myers (BMY) Q4 EarningsWall Street analysts forecast that Bristol Myers Squibb (BMY) will report quarterly earnings of $1.46 per share in its upcoming release, pointing to a year-over-year decline of 14.1%. It is ...
We recently published an article titled Jim Cramer’s Game Plan: 15 Stocks in Focus. In this article, we are going to take a ...
AdvanCell has secured $112 million in a Sanofi Ventures-backed series C funding round as the Australian radiopharma company ...
The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback